A detailed history of Cardinal Capital Management transactions in Biogen Inc. stock. As of the latest transaction made, Cardinal Capital Management holds 30,467 shares of BIIB stock, worth $6.98 Million. This represents 1.08% of its overall portfolio holdings.

Number of Shares
30,467
Previous 27,622 10.3%
Holding current value
$6.98 Million
Previous $7.15 Million 8.09%
% of portfolio
1.08%
Previous 1.36%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024

BUY
$212.02 - $267.71 $603,196 - $761,634
2,845 Added 10.3%
30,467 $6.57 Million
Q4 2023

Jan 26, 2024

SELL
$222.59 - $267.94 $1,780 - $2,143
-8 Reduced 0.03%
27,622 $7.15 Million
Q3 2023

Oct 16, 2023

BUY
$253.3 - $285.89 $91,441 - $103,206
361 Added 1.32%
27,630 $7.1 Million
Q2 2023

Jul 12, 2023

BUY
$275.25 - $318.06 $38,535 - $44,528
140 Added 0.52%
27,269 $7.77 Million
Q1 2023

Apr 18, 2023

SELL
$256.56 - $292.34 $29,247 - $33,326
-114 Reduced 0.42%
27,129 $7.54 Million
Q4 2022

Jan 20, 2023

BUY
$252.44 - $306.72 $771,204 - $937,029
3,055 Added 12.63%
27,243 $0
Q3 2022

Oct 21, 2022

SELL
$194.69 - $268.46 $613,273 - $845,648
-3,150 Reduced 11.52%
24,188 $6.46 Million
Q2 2022

Aug 04, 2022

BUY
$187.54 - $223.02 $16,878 - $20,071
90 Added 0.33%
27,338 $5.58 Million
Q1 2022

Apr 21, 2022

BUY
$193.77 - $244.14 $1.97 Million - $2.48 Million
10,172 Added 59.57%
27,248 $5.74 Million
Q4 2021

Jan 18, 2022

SELL
$223.92 - $287.77 $94,046 - $120,863
-420 Reduced 2.4%
17,076 $4.1 Million
Q3 2021

Oct 21, 2021

SELL
$282.99 - $369.05 $16,696 - $21,773
-59 Reduced 0.34%
17,496 $4.95 Million
Q2 2021

Jul 14, 2021

BUY
$259.0 - $414.71 $49,987 - $80,039
193 Added 1.11%
17,555 $6.08 Million
Q1 2021

Apr 19, 2021

BUY
$242.95 - $284.63 $91,106 - $106,736
375 Added 2.21%
17,362 $4.86 Million
Q4 2020

Feb 01, 2021

BUY
$236.26 - $355.63 $57,883 - $87,129
245 Added 1.46%
16,987 $4.16 Million
Q3 2020

Oct 16, 2020

BUY
$264.77 - $305.71 $794 - $917
3 Added 0.02%
16,742 $4.75 Million
Q2 2020

Jul 16, 2020

SELL
$258.66 - $342.55 $7,501 - $9,933
-29 Reduced 0.17%
16,739 $4.48 Million
Q1 2020

Apr 20, 2020

BUY
$268.85 - $341.04 $10,216 - $12,959
38 Added 0.23%
16,768 $5.31 Million
Q4 2019

Jan 21, 2020

SELL
$220.06 - $304.07 $49,293 - $68,111
-224 Reduced 1.32%
16,730 $4.96 Million
Q3 2019

Oct 18, 2019

SELL
$217.44 - $243.88 $20,439 - $22,924
-94 Reduced 0.55%
16,954 $3.95 Million
Q2 2019

Jul 08, 2019

SELL
$219.29 - $241.72 $38,156 - $42,059
-174 Reduced 1.01%
17,048 $3.99 Million
Q1 2019

Apr 11, 2019

SELL
$216.71 - $338.96 $866 - $1,355
-4 Reduced 0.02%
17,222 $4.07 Million
Q4 2018

Jan 15, 2019

BUY
$278.5 - $352.75 $34,255 - $43,388
123 Added 0.72%
17,226 $5.18 Million
Q3 2018

Oct 25, 2018

SELL
$293.51 - $383.83 $28,763 - $37,615
-98 Reduced 0.57%
17,103 $6.04 Million
Q2 2018

Jul 25, 2018

BUY
$257.52 - $306.91 $4.43 Million - $5.28 Million
17,201 New
17,201 $4.99 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $33B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Cardinal Capital Management Portfolio

Follow Cardinal Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cardinal Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Cardinal Capital Management with notifications on news.